{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T12:43:59Z","timestamp":1754484239009,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T00:00:00Z","timestamp":1564531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000385","name":"Big Lottery Fund","doi-asserted-by":"publisher","award":["10270530"],"award-info":[{"award-number":["10270530"]}],"id":[{"id":"10.13039\/501100000385","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1149-7","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T16:03:55Z","timestamp":1564589035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A cost of illness study evaluating the burden of Wolfram syndrome in the United Kingdom"],"prefix":"10.1186","volume":"14","author":[{"given":"Sana","family":"Eljamel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wrik","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"De Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annabel","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3908-2715","authenticated-orcid":false,"given":"Richard","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,31]]},"reference":[{"key":"1149_CR1","unstructured":"Orphanet. The portal for rare diseases and orphan drugs, Wolfram syndrome. Available from: \n                    http:\/\/www.orpha.net\/consor\/cgi-bin\/OC_Exp.php?lng=EN&Expert=3463\n                    \n                  . Last accessed 19 Oct 2018."},{"key":"1149_CR2","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/S0140-6736(95)92473-6","volume":"346","author":"TG Barrett","year":"1995","unstructured":"Barrett TG, Bundey SE, Macleod AF. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet. 1995;346:1458\u201363.","journal-title":"Lancet."},{"key":"1149_CR3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/ana.22160","volume":"69","author":"A Chaussenot","year":"2011","unstructured":"Chaussenot A, Bannwarth S, Rouzier C, Vialettes B, Mkadem SA, Chabrol B, Cano A, Labauge P, Paquis-Flucklinger V. Neurologic features and genotype-phenotype correlation in Wolfram syndrome. Ann Neurol. 2011;69:501\u20138.","journal-title":"Ann Neurol"},{"key":"1149_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11892-015-0702-6","volume":"16","author":"F Urano","year":"2016","unstructured":"Urano F. Wolfram syndrome: diagnosis, management, and treatment. Curr Diab Rep. 2016;16:6.","journal-title":"Curr Diab Rep"},{"key":"1149_CR5","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1136\/jmg.34.10.838","volume":"34","author":"TG Barrett","year":"1997","unstructured":"Barrett TG, Bundey SE. Wolfram (DIDMOAD) syndrome. J Med Genet. 1997;34:838\u201341.","journal-title":"J Med Genet"},{"key":"1149_CR6","first-page":"156670","volume":"18","author":"BT Kinsley","year":"1995","unstructured":"Kinsley BT, Swift M, Dumont RH, Swift RG. Morbidity and mortality in the Wolfram syndrome. Diabetes Care. 1995;18:156670.","journal-title":"Diabetes Care"},{"key":"1149_CR7","unstructured":"National Health Service. Diabetes UK. Available from: \n                    https:\/\/jdrf.org.uk\/wp-content\/uploads\/2015\/10\/The_United_Kingdom_Insulin_Pump_Audit_May_2013.pdf\n                    \n                  . Last accessed 19 Oct 2018."},{"key":"1149_CR8","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.2337\/dc10-1937","volume":"34","author":"J Rohayem","year":"2011","unstructured":"Rohayem J, Ehlers C, Wiedemann B, Holl R, Oexle K, Kordonouri O, Salzano G, Meissner T, Burger W, Schober E, Huebner A, Lee-Kirsch MA. Diabetes and neurodegeneration in Wolfram syndrome: a multicenter study of phenotype and genotype. Diabetes Care. 2011;34:1503\u201310.","journal-title":"Diabetes Care"},{"key":"1149_CR9","volume-title":"WFS1-related disorders","author":"L Tranebjaerg","year":"2009","unstructured":"Tranebjaerg L. WFS1-related disorders. Seattle: University of Washington, Seattle; 2009."},{"key":"1149_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/j.1464-5491.2009.02775.x","volume":"26","author":"C Pratoomsoot","year":"2009","unstructured":"Pratoomsoot C, Smith HT, Kalsekar A, Boye KS, Arellano J, Valentine WJ. An estimation of the long-term clinical and economic benefits of insulin lispro in type 1 diabetes in the UK. Diabet Med. 2009;26:803\u201314.","journal-title":"Diabet Med"},{"key":"1149_CR11","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1097\/AUD.0b013e3182944db7","volume":"34","author":"RK Karzon","year":"2013","unstructured":"Karzon RK, Hullar TE. Audiologic and vestibular findings in Wolfram syndrome. Ear Hear. 2013;34:809\u201312.","journal-title":"Ear Hear"},{"key":"1149_CR12","unstructured":"National Health Service. NCGC 2012 (2010). Available from: \n                    https:\/\/www.nice.org.uk\/guidance\/cg148\/evidence\/full-guideline-188123437\n                    \n                  . Last accessed 19 Oct 2018."},{"key":"1149_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/0140-6736(90)92157-D","volume":"336","author":"RG Swift","year":"1990","unstructured":"Swift RG, Sadler DB, Swift M. Psychiatric findings in Wolfram syndrome homozygotes. Lancet. 1990;336:667\u20139.","journal-title":"Lancet."},{"key":"1149_CR14","unstructured":"British National Formulary. Available from: \n                    https:\/\/www.bnf.org\/products\/bnf-online\/\n                    \n                  . Last accessed 19 Oct 2018."},{"key":"1149_CR15","doi-asserted-by":"publisher","first-page":"iii","DOI":"10.3310\/hta14110","volume":"14","author":"E Cummins","year":"2010","unstructured":"Cummins E, Royle P, Snaith A, Greene A, Robertson L, McIntyre L, Waugh N. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. Health Technol Assess. 2010;14:iii\u2013iv, xi-xvi, 1\u2013181.","journal-title":"Health Technol Assess"},{"key":"1149_CR16","volume-title":"NHS Wolfram Syndrome Service (Birmingham Children\u2019s Hospital)","author":"Expert Opinion","year":"2016","unstructured":"Expert Opinion. NHS Wolfram Syndrome Service (Birmingham Children\u2019s Hospital). 2016."},{"key":"1149_CR17","volume-title":"NHS Wolfram Syndrome Service (Queen Elizabeth Hospital)","author":"Expert Opinion","year":"2016","unstructured":"Expert Opinion. NHS Wolfram Syndrome Service (Queen Elizabeth Hospital). 2016."},{"key":"1149_CR18","unstructured":"Federation of (Ophthalmic and Dispensing) Opticians. Available from: \n                    http:\/\/www.fodo.com\n                    \n                  . Last accessed 19 Oct 2018."},{"key":"1149_CR19","unstructured":"National Health Service. Reference costs (2015\u20132016). Available from: \n                    https:\/\/www.gov.uk\/government\/publications\/nhs-reference-costs-2015-to-2016\n                    \n                  . Last accessed 19 Oct 2018."},{"key":"1149_CR20","unstructured":"National Health Service. National Tariff (2016-2017). Available from: \n                    https:\/\/www.gov.uk\/government\/publications\/nhs-national-tariff-payment-system-201617\n                    \n                  . Last accessed 19 Oct 2018."},{"key":"1149_CR21","unstructured":"National Health Service. Vale of York CCG. Available from: \n                    https:\/\/www.valeofyorkccg.nhs.uk\/\n                    \n                  . Last accessed 19 Oct 2018."},{"key":"1149_CR22","unstructured":"National Health Service. Drug Tariff (May 2016). Available from: \n                    https:\/\/www.nhsbsa.nhs.uk\/pharmacies-gp-practices-and-appliance-contractors\/drug-tariff\n                    \n                  . Last accessed 19 Oct 2018."},{"key":"1149_CR23","unstructured":"National Health Service. Bolton Foundation Trust (2015). Available from: \n                    http:\/\/www.boltonft.nhs.uk\n                    \n                  . Last accessed 19 Oct 2018."},{"key":"1149_CR24","unstructured":"National Health Service. Southern Derbyshire CCG 2016. Available from: \n                    https:\/\/www.derbyhospitals.nhs.uk\n                    \n                  . Last accessed 19 Oct 2018."},{"key":"1149_CR25","unstructured":"Personal Social Services Research Unit. Available from: \n                    http:\/\/www.pssru.ac.uk\/project-pages\/unit-costs\/2016\/\n                    \n                  . Last accessed 19 Oct 2018."},{"key":"1149_CR26","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1464-5491.2005.01576.x","volume":"22","author":"S Roze","year":"2005","unstructured":"Roze S, Valentine WJ, Zakrzewska KE, Palmer AJ. Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of type 1 diabetes in the UK. Diabet Med. 2005;22:1239\u201345.","journal-title":"Diabet Med"},{"key":"1149_CR27","unstructured":"UK Genetic Testing Network. Available from: \n                    https:\/\/ukgtn.nhs.uk\n                    \n                  . Last accessed 19 Oct 2018."},{"key":"1149_CR28","doi-asserted-by":"publisher","first-page":"877","DOI":"10.5014\/ajot.49.9.877","volume":"49","author":"M Warren","year":"1995","unstructured":"Warren M. Providing low vision rehabilitation services with occupational therapy and ophthalmology: a program description. Am J Occup Ther. 1995;49:877\u201383.","journal-title":"Am J Occup Ther"},{"key":"1149_CR29","unstructured":"Wolfram Syndrome Guideline Development Group. Management of Wolfram Syndrome A Clinical Guideline. 2014. Available from: \n                    http:\/\/www.orpha.net\/national\/data\/IE-EN\/www\/uploads\/Wolfram2014.pdf\n                    \n                  . Last accessed 04 July 2019."},{"key":"1149_CR30","unstructured":"Findacure. Patient focus group report: Wolfram syndrome. 2016. Available from: \n                    https:\/\/www.findacure.org.uk\/wp-content\/uploads\/2018\/06\/Wolfram-syndrome-Findacure-Rare-Disease-Perspectives-2016.pdf\n                    \n                  . Last accessed 04 July 2019."},{"key":"1149_CR31","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.healthpol.2014.12.016","volume":"119","author":"A Angelis","year":"2015","unstructured":"Angelis A, Tordrup D, Kanavos P. Socio-economic burden of rare diseases: a systematic review of cost of illness evidence. Health Policy. 2015;119:964\u201379.","journal-title":"Health Policy"},{"key":"1149_CR32","volume-title":"Niemann-pick disease type C. GeneReviews\u00ae","author":"M Patterson","year":"1993","unstructured":"Patterson M. Niemann-pick disease type C. GeneReviews\u00ae. Seattle: University of Washington, Seattle; 1993."},{"key":"1149_CR33","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3111\/13696990903245863","volume":"12","author":"J Imrie","year":"2009","unstructured":"Imrie J, Galani C, Gairy K, Lock K, Hunsche E. Cost of illness associated with Niemann-pick disease type C in the UK. J Med Econ. 2009;12:219\u201329.","journal-title":"J Med Econ"},{"key":"1149_CR34","doi-asserted-by":"publisher","first-page":"e4134","DOI":"10.1371\/journal.pone.0004134","volume":"4","author":"C Kakiuchi","year":"2009","unstructured":"Kakiuchi C, Ishigaki S, Oslowski CM, Fonseca SG, Kato T, Urano F. Valproate, a mood stabilizer, induces WFS1 expression and modulates its interaction with ER stress protein GRP94. PLoS One. 2009;4:e4134.","journal-title":"PLoS One"},{"key":"1149_CR35","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s13105-011-0088-0","volume":"67","author":"A Terasmaa","year":"2011","unstructured":"Terasmaa A, Soomets U, Oflijan J, Punapart M, Hansen M, Matto V, Ehrlich K, Must A, Koks S, Vasar E. Wfs1 mutation makes mice sensitive to insulin-like effect of acute valproic acid and resistant to streptozocin. J Physiol Biochem. 2011;67:381\u201390.","journal-title":"J Physiol Biochem"},{"key":"1149_CR36","unstructured":"European Parliament and of the Council Regulation (EC) 141\/2000 of 16 December 1999 on Orphan Medicinal Products. OJL 018\/1, 22.01.2000. Available from: \n                    https:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:L:2000:018:0001:0005:en:PDF\n                    \n                  . Last accessed 19 Oct 2018."},{"key":"1149_CR37","unstructured":"UK Department of Health. The UK Strategy for Rare Diseases. Available from: \n                    http:\/\/www.raredisease.org.uk\/uk-strategy-for-rare-diseases\/\n                    \n                  . Last accessed 19 Oct 2018."},{"key":"1149_CR38","unstructured":"RARE-Bestpractices. Available from: \n                    http:\/\/www.rarebestpractices.eu\/\n                    \n                  . Last accessed 19 Oct 2018."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1149-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1149-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1149-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T23:25:35Z","timestamp":1596065135000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1149-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,31]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1149"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1149-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"type":"electronic","value":"1750-1172"}],"subject":[],"published":{"date-parts":[[2019,7,31]]},"assertion":[{"value":"19 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors of the manuscript have read and agreed to its content and are accountable for all aspects of the accuracy and integrity of the manuscript in accordance with ICMJE criteria.This article is original, has not already been published in a journal, and is not currently under consideration by another journal. Results from this model have previously been presented at the 2016 International Society for Pharmacoeconomics and Outcomes Research European conference and have since been updated for this manuscript.All authors agree to the terms of the BioMed Central Copyright and License Agreement.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"At the time of study, authors SE and SDS were affiliated with Costello Medical. SE is currently affiliated with the Acteon Consultancy LLP, and SDS is currently affiliated with the University of Warwick. The authors have nothing further to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"185"}}